$CLMT

S&P upgrades Calumet rating to B- on stronger earnings

S&P Global Ratings upgraded Calumet Inc. to 'B-' from 'CCC+' due to stronger earnings in H1 2026 and improved credit metrics. The company's earnings grew on high margins for specialty oils and renewable fuels. S&P expects adjusted debt to EBITDA of 6x-7x in the next 12 months. Calumet redeemed $100M in senior unsecured notes in July 2026 and plans to expand sustainable aviation fuel production.

Original reporting
Published Aug 27, 2026, 7:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 8:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CLMT
Bullish
high confidence
Mentioned
$CLMT
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$CLMTBullishMed
01

Why it matters

The upgrade reduces perceived default risk, likely encouraging bond and equity investors to increase exposure.

02

Market read

The rating upgrade is a material credit event for CLMT, offering a potential trading edge for credit‑focused investors.

03

What to watch

Potential exposure to rising RIN obligations could offset credit improvements.

Relevance 7/10Novelty 7/10Timing: today

Background

Calumet Inc. reported strong first‑half 2026 earnings from specialty oils and renewable fuel margins, prompting S&P to raise its credit rating.

Company-level read

Ticker impact

$CLMTBullishHigh confidence
Context

S&P Global Ratings upgraded Calumet Inc. to B- from CCC+ citing stronger-than-expected earnings and improved credit metrics.

Expected impact

Potential short-term price appreciation as investors reprice credit risk.

Evidence & confidence

Credit rating upgrades historically lead to price gains for the issuer, especially when driven by earnings momentum.

Market effects

Improved credit outlook may lift sentiment in the specialty oils and renewable fuels sector.

U.S. energy stocks could see modest gains as credit conditions tighten.

Limited to investors tracking credit quality of mid-cap energy producers.

Counterpoint

If the rating upgrade is already priced in, the stock may face a short-term pullback.

Key entities

  • Calumet Inc.

    U.S. specialty oils and renewable fuels producer (ticker CLMT).

  • S&P Global Ratings

    Provided the B- credit rating upgrade.

Related articles

$CLMTMedAI 8/10

Calumet (CLMT) Q2 2026 Earnings Call Transcript

Calumet (CLMT) reported Q2 2026 Adjusted EBITDA with Tax Attributes of $175.2 million, driven by Specialty Products and Solutions at $161.7 million. Net loss was $95.9 million, mainly from non-cash RINs expenses of $163.6 million. The company said it repaid $115 million of debt in July, including $100 million note redemption, and discussed SAF expansion and hedges.

$CLMTMed

Why Calumet Stock Is Rocketing Higher Today

Calumet (CLMT) shares rose 15.2% to about $5.99 by 2:36 p.m. ET after a 6.8% drop the prior week. Bank of America kept a buy rating and raised its price target to $45 from $38, citing stronger free cash flow and debt retirement. Calumet reported about $54M free cash flow in Q2 2026 and retired $115M debt in July.

$CLMTMedAI 8/10

CLMT Stock Jumps As Revenue Beats And Debt Falls

Calumet Inc (NASDAQ: CLMT) shares rose about 10.56% after Q2 results and guidance. The company reported Q2 revenue of $1.45B versus a FactSet estimate of $1.12B, with EPS improving to -$1.09 from -$1.70. Operating cash flow was about $92.3M and free cash flow about $54M, alongside $115M debt reduction in July. Goldman Sachs raised its CLMT price target to $40 from $36 but kept a Neutral rating.

$CLMTMed

CLMT Stock Jumps As Revenue Beat Fuels Deleveraging Story

Calumet Inc. (CLMT) shares rose about 10.56% after the company reported Q2 revenue of $1.45B versus $1.12B expected, and narrowed its EPS loss to -$1.09 from -$1.70. The quarter included $54M free cash flow and management cited $115M debt reduction in July, alongside a MaxSAF 150 expansion at Montana Renewables.

$CLMTMed

Why Calumet Stock Flopped on Friday

Calumet (CLMT) shares fell about 6% on Friday after its Q2 earnings showed a surprise net loss. Revenue rose to just under $1.45B, up about 41% YoY, but adjusted net loss was $95.9M, or $1.09/share, versus a year-ago deficit of $147.9M. Analysts expected profit of $0.17/share. Long-term debt exceeded $2.2B.

$CLMTMed

Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026

Calumet (NASDAQ:CLMT) reported Q2 CY2026 results. Revenue rose 40.8% year on year to $1.45 billion, beating Wall Street estimates by 32% (according to the article). Adjusted EBITDA exceeded consensus by 78.2%, with margin rising to 12.1%. Free cash flow was $99.35 million, turning positive after a year-ago loss.